MedPath
FDA Approval

Gentamicin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Gentamicin(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC

023648251

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gentamicin

Product Details

NDC Product Code
63323-173
Application Number
ANDA062366
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
September 2, 2021
Code: 8X7386QRLVClass: ACTIMQuantity: 10 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
© Copyright 2025. All Rights Reserved by MedPath